GlassScriptPhysician profile
Rachel Saavedra
NPI 1568786820
$3,478.27
in general payments reported to CMS, 2019-2025
11 companies · $1,702 in 2025
The $1,702 reported for 2025 was more than what 93% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $159 · 2022: $175 · 2023: $535 · 2024: $908 · 2025: $1,702.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,950 · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,949.65 |
| Food and Beverage | $1,195.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,516.74 | 2023-2025 | |
| Allergan, INC. | $234.07 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $169.28 | 2022-2025 | Ingrezza |
| Abbott Laboratories | $133.10 | 2024 | Proclaim |
| Astrazeneca Pharmaceuticals LP | $111.67 | 2021 | |
| Silk Road Medical, INC. | $93.72 | 2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Lilly USA, LLC | $86.28 | 2021-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $54.51 | 2025 | Wegovy |
| Corium, LLC | $45.70 | 2023 | Azstarys |
| Exact Sciences Corporation | $17.28 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $15.92 | 2023 | Abilify Asimtufii, Abilify Maintena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Saavedra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.